Companion Diagnostic 64Cu-Liposome Positron Emission Tomography Enables Characterization of Drug Delivery to Tumors and Predicts Response to Cancer Nanomedicines. (Q55265623)

From Wikidata

Jump to navigation Jump to search

scientific article published on 21 March 2018

Language	Label	Description	Also known as
English	Companion Diagnostic 64Cu-Liposome Positron Emission Tomography Enables Characterization of Drug Delivery to Tumors and Predicts Response to Cancer Nanomedicines.	scientific article published on 21 March 2018

Statements

scholarly article

1 reference

Europe PubMed Central

PMC publication ID

29 June 2018

http://europepmc.org/abstract/PMC/5928891

Companion Diagnostic 64Cu-Liposome Positron Emission Tomography Enables Characterization of Drug Delivery to Tumors and Predicts Response to Cancer Nanomedicines. (English)

1 reference

Europe PubMed Central

PMC publication ID

29 June 2018

http://europepmc.org/abstract/PMC/5928891

1 reference

based on heuristic

inferred from title

positron emission tomography

1 reference

based on heuristic

inferred from title

0 references

Dmitri B. Kirpotin

object named as

Dmitri Kirpotin

6

0 references

author name string

Helen Lee

1

1 reference

Europe PubMed Central

PMC publication ID

29 June 2018

http://europepmc.org/abstract/PMC/5928891

Daniel Gaddy

2

1 reference

Europe PubMed Central

PMC publication ID

29 June 2018

http://europepmc.org/abstract/PMC/5928891

Manuela Ventura

3

1 reference

Europe PubMed Central

PMC publication ID

29 June 2018

http://europepmc.org/abstract/PMC/5928891

Nicholas Bernards

4

1 reference

Europe PubMed Central

PMC publication ID

29 June 2018

http://europepmc.org/abstract/PMC/5928891

Raquel de Souza

5

1 reference

Europe PubMed Central

PMC publication ID

29 June 2018

http://europepmc.org/abstract/PMC/5928891

Thomas Wickham

7

1 reference

Europe PubMed Central

PMC publication ID

29 June 2018

http://europepmc.org/abstract/PMC/5928891

Jonathan Fitzgerald

8

1 reference

Europe PubMed Central

PMC publication ID

29 June 2018

http://europepmc.org/abstract/PMC/5928891

Jinzi Zheng

9

1 reference

Europe PubMed Central

PMC publication ID

29 June 2018

http://europepmc.org/abstract/PMC/5928891

Bart S Hendriks

10

1 reference

Europe PubMed Central

PMC publication ID

29 June 2018

http://europepmc.org/abstract/PMC/5928891

publication date

21 March 2018

1 reference

Europe PubMed Central

PMC publication ID

29 June 2018

http://europepmc.org/abstract/PMC/5928891

1 reference

Europe PubMed Central

PMC publication ID

29 June 2018

http://europepmc.org/abstract/PMC/5928891

8

1 reference

Europe PubMed Central

PMC publication ID

29 June 2018

http://europepmc.org/abstract/PMC/5928891

9

1 reference

Europe PubMed Central

PMC publication ID

29 June 2018

http://europepmc.org/abstract/PMC/5928891

2300-2312

1 reference

Europe PubMed Central

PMC publication ID

29 June 2018

http://europepmc.org/abstract/PMC/5928891

Nanoreporter PET predicts the efficacy of anti-cancer nanotherapy.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5928891

30 June 2018

Predicting therapeutic nanomedicine efficacy using a companion magnetic resonance imaging nanoparticle.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5928891

30 June 2018

Cyclophosphamide-Mediated Tumor Priming for Enhanced Delivery and Antitumor Activity of HER2-Targeted Liposomal Doxorubicin (MM-302).

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5928891

30 June 2018

Whole-body organ-level and kidney micro-dosimetric evaluations of (64)Cu-loaded HER2/ErbB2-targeted liposomal doxorubicin ((64)Cu-MM-302) in rodents and primates.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5928891

30 June 2018

Toward a full understanding of the EPR effect in primary and metastatic tumors as well as issues related to its heterogeneity

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5928891

30 June 2018

A gradient-loadable (64)Cu-chelator for quantifying tumor deposition kinetics of nanoliposomal therapeutics by positron emission tomography

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5928891

30 June 2018

Nanomedicine for drug targeting: strategies beyond the enhanced permeability and retention effect

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5928891

30 June 2018

Challenges and key considerations of the enhanced permeability and retention effect for nanomedicine drug delivery in oncology

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5928891

30 June 2018

HER2-targeted liposomal doxorubicin displays enhanced anti-tumorigenic effects without associated cardiotoxicity

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5928891

30 June 2018

Targeted drug delivery to tumors: Myths, reality and possibility

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5928891

30 June 2018

Imaging nanoprobe for prediction of outcome of nanoparticle chemotherapy by using mammography.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5928891

30 June 2018

Enhanced permeability and retention of macromolecular drugs in solid tumors: a royal gate for targeted anticancer nanomedicines.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5928891

30 June 2018

Pharmacokinetics of pegylated liposomal Doxorubicin: review of animal and human studies

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5928891

30 June 2018

Effective targeting of solid tumors in patients with locally advanced cancers by radiolabeled pegylated liposomes.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5928891

30 June 2018

Optimizing liposomes for delivery of chemotherapeutic agents to solid tumors.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5928891

30 June 2018

Characterization of N-ethyl-N-nitrosourea-induced malignant and benign breast tumors in rats by using three MR contrast agents

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5928891

30 June 2018

A new concept for macromolecular therapeutics in cancer chemotherapy: mechanism of tumoritropic accumulation of proteins and the antitumor agent smancs

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5928891

30 June 2018

64Cu-MM-302 Positron Emission Tomography Quantifies Variability of Enhanced Permeability and Retention of Nanoparticles in Relation to Treatment Response in Patients with Metastatic Breast Cancer.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5928891

12 August 2018

Correlation between Ferumoxytol Uptake in Tumor Lesions by MRI and Response to Nanoliposomal Irinotecan in Patients with Advanced Solid Tumors: A Pilot Study

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5928891

12 August 2018

Positron Emission Tomography Based Elucidation of the Enhanced Permeability and Retention Effect in Dogs with Cancer Using Copper-64 Liposomes.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5928891

12 August 2018

Multiscale kinetic modeling of liposomal Doxorubicin delivery quantifies the role of tumor and drug-specific parameters in local delivery to tumors

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5928891

12 August 2018

Development of a highly active nanoliposomal irinotecan using a novel intraliposomal stabilization strategy

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5928891

12 August 2018

Correlation of dynamic contrast-enhanced MR imaging with histologic tumor grade: comparison of macromolecular and small-molecular contrast media

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5928891

12 August 2018

Physiologically based pharmacokinetic model for specific and nonspecific monoclonal antibodies and fragments in normal tissues and human tumor xenografts in nude mice.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5928891

12 August 2018

Vascular permeability in a human tumor xenograft: molecular size dependence and cutoff size

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5928891

12 August 2018

Antibody Targeting of Long-Circulating Lipidic Nanoparticles Does Not Increase Tumor Localization but Does Increase Internalization in Animal Models

1 reference

https://pubmed.ncbi.nlm.nih.gov/29721081

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Preclinical activity of nanoliposomal irinotecan is governed by tumor deposition and intratumor prodrug conversion

1 reference

https://pubmed.ncbi.nlm.nih.gov/29721081

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.7150/THNO.21670

1 reference

Europe PubMed Central

PMC publication ID

29 June 2018

http://europepmc.org/abstract/PMC/5928891

PMC publication ID

1 reference

Europe PubMed Central

PMC publication ID

29 June 2018

http://europepmc.org/abstract/PMC/5928891

PubMed publication ID

1 reference

Europe PubMed Central

PMC publication ID

29 June 2018

http://europepmc.org/abstract/PMC/5928891

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q55265623&oldid=2187487199"